Publications

Found 6 results
Filters: Author is Van Ginderachter, Jo A  [Clear All Filters]
2016
Stijlemans, B., G. Caljon, J. Van Den Abbeele, J. A. Van Ginderachter, S. Magez, and C. De Trez, "Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to Pathogenicity.", Front Immunol, vol. 7, pp. 233, 2016.
Stijlemans, B., L. Brys, H. Korf, P. Bieniasz-Krzywiec, A. Sparkes, L. Vansintjan, L. Leng, N. Vanbekbergen, M. Mazzone, G. Caljon, et al., "MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis.", PLoS Pathog, vol. 12, issue 9, pp. e1005862, 2016 Sep.
Sparkes, A., P. De Baetselier, K. Roelants, C. De Trez, S. Magez, J. A. Van Ginderachter, G. Raes, R. Bucala, and B. Stijlemans, "The non-mammalian MIF superfamily.", Immunobiology, 2016 Oct 12.
2015
Stijlemans, B., A. Beschin, S. Magez, J. A. Van Ginderachter, and P. De Baetselier, "Iron Homeostasis and Trypanosoma brucei Associated Immunopathogenicity Development: A Battle/Quest for Iron.", Biomed Res Int, vol. 2015, pp. 819389, 2015.
2013
Gad, W., M. G. Nair, K. Van Belle, K. Wahni, H. De Greve, J. A. Van Ginderachter, G. Vandenbussche, Y. Endo, D. Artis, and J. Messens, "The quiescin sulfhydryl oxidase (hQSOX1b) tunes the expression of resistin-like molecule alpha (RELM-α or mFIZZ1) in a wheat germ cell-free extract.", PLoS One, vol. 8, issue 1, pp. e55621, 2013.
2009
De Vocht, C., A. Ranquin, R. Willaert, J. A. Van Ginderachter, T. Vanhaecke, V. Rogiers, W. Versées, P. Van Gelder, and J. Steyaert, "Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE.", J Control Release, vol. 137, issue 3, pp. 246-54, 2009 Aug 4.